Perspective Therapeutics Inc. (CATX) — Capital Reinvestment Ratio
Perspective Therapeutics Inc. (CATX) has a Capital Reinvestment Ratio of 8.83x as of September 2024, meaning it reinvests 9% of its operating cash flow ($3.37 Million) in capital expenditures ($29.71 Million). See CATX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Perspective Therapeutics Inc. Capital Reinvestment Ratio (1999–2001)
This chart tracks Perspective Therapeutics Inc.'s Capital Reinvestment Ratio across 4 annual periods. See CATX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Capital Reinvestment Ratio for Perspective Therapeutics Inc. (1999–2001)
Year-by-year Capital Reinvestment Ratio for Perspective Therapeutics Inc. from 1999 to 2001. For the full cash flow conversion analysis, see Perspective Therapeutics Inc. (CATX) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2001 | 0.13x | $365.34K | $48.81K | ▲ +0.0% |
| 2000 | 0.13x | $365.34K | $48.81K | ▼ -76.9% |
| 1999 | 0.58x | $275.97K | $159.58K | ▲ +0.0% |
| 1999 | 0.58x | $275.97K | $159.58K | — |